Mazyar Shadman, MD, MPH

Mazyar Shadman, MD, MPH

Assistant Member
Clinical Research Division
Assistant Professor, Medical Oncology Division, Department of Medicine
University of Washington
Attending Physician, Hematologic Malignancies
Seattle Cancer Care Alliance (SCCA)

Education

MD, Tehran University of Medical Sciences, 2004
Internal Medicine Residency : Cleveland Clinic, 2008-2011
Hematology and Medical Oncology fellowship: University of Washington/Fred Hutchinson Cancer Research Center, 2011-2014
MPH, (Cancer Epidemiology): University of Washington 2008

Research Focus

  • Therapeutic clinical trials in lymphoid malignancies with a focus on chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
  • Clinical outcome research in hematopoietic cell transplantation
  • Epidemiology of hematologic malignancies

Clinical Expertise

  • Hematologic malignancies
  • Hematopoietic cell transplantation

Current Studies

  • Idelalisib + Bendamustine and Rituximab for Untreated CLL (9064)
  • Ibrutinib + Rituximab vs. Fludarabine Phosphate, Cyclophosphamide, and Rituximab for Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (E1912)

Clinical Trials

Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination with Chlorambucil, ACP-196 in Combination with Obinutuzumab, and ACP-196 Monotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia

A Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With TGR-1202 Compared to Obinutuzumab in Combination With Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL) (FH9657)

Phase 1/2 Study to Determine the Safety, Pharmacokinetics, and Efficacy of Single Agent CC-122 and the Combinations CC-122 AND Ibrutinib and CC-122 and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (FH9597)



Related Labs & Projects

View all labs & projects >
Mazyar Shadman, MD, MPH

Contact Information

Phone
(206) 667-5467
Fax
(206) 667-1874
Email
Additional contact

Mail Stop: D3-190